Survodutide research: examining a dual-agonist framework Survodutide, also identified in the literature as BI 456906, is a synthetic acylated peptide studied for co-agonism at the GLP-1 and glucagon receptors. It is useful to researchers because it brings two receptor systems into one experimental framework and therefore requires careful pathway attribution. This review is confined to […]
